BRIEF-Cell Therapeutics jumps in premarket after opaxiotm gets orphan drug designation

NEW YORK Tue Oct 2, 2012 7:47am EDT

NEW YORK Oct 2 (Reuters) - Cell Therapeutics Inc : * Jumps 23.3 percent to $2.75 in premarket after opaxiotm gets orphan drug designation from U.S. Food and Drug Administration for malignant brain cancer

FILED UNDER: